Aspirin, NSAIDs, and COX-2 inhibitors in cardiovascular disease: possible interactions and implications for treatment of rheumatoid arthritis

Current Rheumatology Reports
Tobias KurthJ Michael Gaziano

Abstract

Aspirin, nonsteroidal antiinflammatory drugs (NSAIDs), and cyclooxygenase-2 (COX-2) inhibitors are widely used in patients with rheumatoid arthritis. Aspirin has the largest and most persuasive body of randomized trial evidence to support its use in secondary prevention for cardiovascular disease (CVD) and primary prevention for myocardial infarction. There is, however, a possible deleterious interaction between aspirin and NSAIDs on CVD that requires further research. Aspirin, NSAIDs, and to a lesser extent COX-2 inhibitors are associated with increased gastrointestinal side effects and bleeding, alone and in combination. The more widespread and appropriate use of aspirin in patients with rheumatoid arthritis will avoid many premature deaths in secondary prevention for CVD and first myocardial infarctions in primary prevention.

References

Dec 1, 1991·Journal of Neurology, Neurosurgery, and Psychiatry·B FarrellC Warlow
Jul 20, 1989·The New England Journal of Medicine·UNKNOWN Steering Committee of the Physicians' Health Study Research Group
Apr 1, 1987·Statistics in Medicine·C H HennekensP R Hebert
Jan 1, 1985·Clinical Pharmacology and Therapeutics·A K Pedersen, G A FitzGerald
Jul 1, 1983·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·G H RaoJ G White
Aug 15, 1994·Annals of Internal Medicine·A G JohnsonR O Day
Feb 22, 1993·Archives of Internal Medicine·J E PopeD T Felson
Nov 23, 2000·The New England Journal of Medicine·C BombardierUNKNOWN VIGOR Study Group
Aug 11, 2001·The New England Journal of Medicine·G A FitzGerald, C Patrono
Aug 31, 2001·JAMA : the Journal of the American Medical Association·D MukherjeeE J Topol
Dec 26, 2001·The New England Journal of Medicine·F Catella-LawsonG A FitzGerald
Jan 16, 2002·Annals of Internal Medicine·UNKNOWN U.S. Preventive Services Task Force
May 22, 2002·Archives of Internal Medicine·Daniel H SolomonJerry Avorn
May 22, 2002·Archives of Internal Medicine·Douglas J WatsonHarry A Guess
May 22, 2002·Archives of Internal Medicine·Elham RahmeJacques LeLorier
Oct 24, 2002·Archives of Internal Medicine·Gary C CurhanMeir J Stampfer
Nov 2, 2002·Hypertension·Julien DedierGary C Curhan
Jan 16, 2003·Arthritis and Rheumatism·Colin Baigent, Carlo Patrono
Feb 25, 2003·Lancet·T M MacDonald, L Wei
Mar 12, 2003·Circulation·Daniel H SolomonGary C Curhan
May 21, 2003·Annals of Internal Medicine·Brennan M R SpiegelIan M Gralnek
Sep 25, 2003·Archives of Internal Medicine·Rachel S EidelmanCharles H Hennekens
Dec 6, 2003·BMJ : British Medical Journal·Stephen E Kimmel, Brian L Strom
Dec 6, 2003·BMJ : British Medical Journal·Jeptha P CurtisHarlan M Krumholz
Dec 19, 2003·Expert Opinion on Pharmacotherapy·Adam Williams, Charles H Hennekens
Jan 13, 2004·The American Journal of Cardiology·Lorenz M FischerChristoph R Meier
Apr 28, 2004·Archives of Internal Medicine·Taral N Patel, Kenneth Charles Goldberg
Jun 16, 2004·Circulation·Luis A García RodríguezAntonio González-Pérez

❮ Previous
Next ❯

Citations

Jul 12, 2007·Pharmacogenetics and Genomics·Yu ChenJohanna W Lampe
May 10, 2008·Journal of the American College of Cardiology·Armen Yuri GasparyanGregory Y H Lip
May 5, 2005·The Annals of Pharmacotherapy·Shelby L CormanNicole T Ansani
Jun 27, 2013·Oncology Reports·Kun-Huang YanShuang-En Chuang
May 7, 2019·Frontiers in Cellular and Infection Microbiology·Shyamala Thirunavukkarasu, Shabaana A Khader
Oct 4, 2018·European Journal of Clinical Pharmacology·Tahmina Nasrin PolyYu-Chuan Jack Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.